C. Peterfy

发表

SAT0575 Safety and efficacy of lutikizumab (ABT-981), an anti–interleukin-1 alpha/beta dual variable domain (DVD) immunoglobulin, in subjects with knee osteoarthritis: results from the randomised, double-blind, placebo-controlled, parallel-group phase 2 trial

Lu Wang, J. Pelletier, J. Martel-Pelletier, 2018, Saturday, 16 JUNE 2018.

Clinical and epidemiological research

P. Tak, C. Peterfy, W. Stohl, 2011 .

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

P. Tak, C. Peterfy, P. Tak, 2010, Annals of the rheumatic diseases.

SAT0168 Mri results following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomized controlled trial

W. Reiss, C. Birchwood, M. Michalska, 2018, Saturday, 16 JUNE 2018.

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE

W. Stohl, T. Shaw, E. Hessey, 2011, Annals of the rheumatic diseases.

The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy

C. Peterfy, J. DiCarlo, P. Conaghan, 2014, Annals of the rheumatic diseases.

Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis.

R Burgkart, F Eckstein, S Totterman, 2006, Osteoarthritis and cartilage.

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial

Xianhuang Zhou, C. Peterfy, Tracy Li, 2011, Annals of the rheumatic diseases.

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

M. Dougados, H. Genant, I. Logeart, 2009, Annals of the rheumatic diseases.

Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study

P. Durez, E. Mysler, Yihan Li, 2024, RMD open.